http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113908119-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f99af518be69354261ac829807d6ebbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fd33042b7a881e181f69379f60b36f7 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
filingDate | 2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46eb519b940f5f659386353ec2511017 |
publicationDate | 2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113908119-A |
titleOfInvention | A kind of inosine injection with remarkable effect of intravenous injection and preparation method thereof |
abstract | The invention disclosed in the invention belongs to the technical field of medicine, in particular to an inosine injection with remarkable intravenous injection effect and a preparation method thereof. The injection consists of the following raw materials in parts by weight: inosine, propylene glycol, sodium hydroxide, anhydrous sodium sulfite, The invention can effectively relieve the adverse reactions of nausea and vomiting when using the injection to relieve the intravenous drip, at the same time reduce the stimulation to the blood vessels, and can be used for the rescue treatment of pulmonary heart disease in the form of intravenous injection, and the drug approval process Both the clinical application and the focus on "intravenous injection" and "intravenous injection" have significant effects as the core, and the injection can be prevented from being oxidized by anhydrous sodium sulfite. At the same time, the injection is prepared under the protection of carbon dioxide gas, which can effectively reduce At the same time, flushing nitrogen gas when filling the injection can effectively prevent the problem of oxidative deterioration and ensure the stability and safety of the injection. |
priorityDate | 2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.